• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数降低的心力衰竭患者健康相关生活质量不存在肥胖悖论:VIDA多中心研究的见解

No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study.

作者信息

Cassadó-Valls Paula, Enjuanes Cristina, Anguita Manuel, Formiga Francesc, Almenar Luis, Crespo-Leiro María G, Manzano Luis, Muñiz Javier, Chaves José, Hidalgo Encarna, Ramos-Polo Raúl, Yun Sergi, José-Bazán Núria, Moliner Pedro, Comín-Colet Josep

机构信息

School of Medicine, University of Barcelona, 08097 Barcelona, Spain.

Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

出版信息

J Clin Med. 2024 Dec 12;13(24):7558. doi: 10.3390/jcm13247558.

DOI:10.3390/jcm13247558
PMID:39768481
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11728257/
Abstract

Previous studies showed that, paradoxically, obese patients with heart failure (HF) have better clinical outcomes compared to overweight, normal, or underweight patients. Scientific societies emphasize the importance of integrating quality of life (QoL) assessment in cardiovascular care. However, the association between QoL and weight remains understudied. Given the significant correlation between HF survival and QoL, it is essential to assess how obesity impacts patient-reported outcomes in this clinical setting. This cross-sectional multicenter study in 1028 HF patients with reduced ejection fraction (HFrEF) aims to evaluate the association between obesity and QoL, and whether the obesity paradox holds for HF patients regarding QoL. Specific and generic QoL questionnaires were administered alongside clinical parameters like body mass index (BMI) and body adiposity estimator (BAE). Obese compared to non-obese reported worse QoL. In the adjusted linear regression models, neither BMI nor obesity were associated with QoL. Generalized additive models confirmed a strong non-parametric association between BMI, subdomain scores from Kansas City Cardiomyopathy Questionnaire (KCCQ) (OSS = 0.004, CSS = 0.006, TSS = 0.02), and summary measurements of EQ-5D (EQ-5D index = 0.003, visual analogue scale (VAS) = 0.01). In contrast, BAE showed a statistically significant linear relation among QoL (OSS ≤ 0.001, CSS ≤ 0.001, TSS ≤ 0.001) and EQ-5D summary measurements (EQ-5D index ≤ 0.001, VAS ≤ 0.001). : Overall, obese patients have worse QoL; therefore, obesity cannot be considered a protective factor in terms of QoL in established HF.

摘要

以往研究表明,矛盾的是,与超重、体重正常或体重过轻的心力衰竭(HF)患者相比,肥胖的HF患者临床结局更好。科学协会强调在心血管护理中纳入生活质量(QoL)评估的重要性。然而,QoL与体重之间的关联仍未得到充分研究。鉴于HF生存率与QoL之间存在显著相关性,评估肥胖在这种临床情况下如何影响患者报告的结局至关重要。这项针对1028例射血分数降低的HF患者(HFrEF)的横断面多中心研究旨在评估肥胖与QoL之间的关联,以及肥胖悖论在HF患者的QoL方面是否成立。除了体重指数(BMI)和身体脂肪估计值(BAE)等临床参数外,还使用了特定和通用的QoL问卷。与非肥胖患者相比,肥胖患者报告的QoL更差。在调整后的线性回归模型中,BMI和肥胖均与QoL无关。广义相加模型证实BMI与堪萨斯城心肌病问卷(KCCQ)的子域评分(总体症状评分(OSS)=0.004,临床症状评分(CSS)=0.006,总分(TSS)=0.02)以及欧洲五维健康量表(EQ-5D)的汇总测量值(EQ-5D指数=0.003,视觉模拟量表(VAS)=0.01)之间存在强烈的非参数关联。相比之下,BAE在QoL(OSS≤0.001,CSS≤0.001,TSS≤0.001)和EQ-5D汇总测量值(EQ-5D指数≤0.001,VAS≤0.001)之间显示出统计学上显著的线性关系。总体而言,肥胖患者的QoL更差;因此,在已确诊的HF中,就QoL而言,肥胖不能被视为一个保护因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/760f192f9467/jcm-13-07558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/75b53649e8c5/jcm-13-07558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/fef860b35a0a/jcm-13-07558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/760f192f9467/jcm-13-07558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/75b53649e8c5/jcm-13-07558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/fef860b35a0a/jcm-13-07558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3dc/11728257/760f192f9467/jcm-13-07558-g003.jpg

相似文献

1
No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study.射血分数降低的心力衰竭患者健康相关生活质量不存在肥胖悖论:VIDA多中心研究的见解
J Clin Med. 2024 Dec 12;13(24):7558. doi: 10.3390/jcm13247558.
2
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.达格列净对射血分数降低和轻度降低/保留的心力衰竭患者生活质量的影响,采用欧洲五维健康量表问卷进行评估。
Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3.
3
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.心力衰竭男性和女性的生活质量:与预后的关联以及堪萨斯城心肌病问卷和欧洲五维健康量表的比较
Eur J Heart Fail. 2021 Apr;23(4):567-577. doi: 10.1002/ejhf.2154. Epub 2021 May 4.
4
Assessing the diversity and determinants of health-related quality of life measures in patients with acute heart failure.评估急性心力衰竭患者健康相关生活质量测量的多样性和决定因素。
ESC Heart Fail. 2024 Aug;11(4):1963-1970. doi: 10.1002/ehf2.14745. Epub 2024 Mar 20.
5
EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction: A Patient-Level Analysis of DAPA-HF and DELIVER.射血分数降低、轻度降低和保留的心力衰竭患者的欧洲五维健康量表问卷:DAPA-HF和DELIVER研究的患者水平分析
JACC Heart Fail. 2025 Feb;13(2):277-292. doi: 10.1016/j.jchf.2024.10.020.
6
Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study.基于办公室和家庭的射血分数降低型心力衰竭患者生活质量评估:一项随机研究。
Int J Cardiol. 2024 Oct 15;413:132341. doi: 10.1016/j.ijcard.2024.132341. Epub 2024 Jul 4.
7
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.SOCRATES-PRESERVED 研究:射血分数保留的心力衰竭患者中可溶性鸟苷酸环化酶刺激剂的患者报告结局。
Eur J Heart Fail. 2017 Jun;19(6):782-791. doi: 10.1002/ejhf.800.
8
Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study.考虑在初级保健中使用通用 EQ-5D-5L™,与心力衰竭患者生活质量相关的预后因素:观察性 RECODE-HF 研究的新随访结果。
BMC Fam Pract. 2021 Oct 13;22(1):202. doi: 10.1186/s12875-021-01554-1.
9
Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.评估在门诊就诊的心力衰竭患者的健康相关生活质量:一种实用方法。
ESC Heart Fail. 2019 Feb;6(1):3-9. doi: 10.1002/ehf2.12363. Epub 2018 Oct 11.
10
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.合并症对心力衰竭伴射血分数降低和保留患者健康状况(采用堪萨斯城心肌病问卷进行测量)的影响。
Eur J Heart Fail. 2023 Sep;25(9):1606-1618. doi: 10.1002/ejhf.2962. Epub 2023 Aug 3.

本文引用的文献

1
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.体格测量指标与射血分数降低型心力衰竭不良结局:重新审视肥胖悖论。
Eur Heart J. 2023 Apr 1;44(13):1136-1153. doi: 10.1093/eurheartj/ehad083.
2
Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study.西班牙射血分数降低的心力衰竭患者的生活质量和疾病体验:混合方法研究。
BMJ Open. 2021 Dec 3;11(12):e053216. doi: 10.1136/bmjopen-2021-053216.
3
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease.
真正重要的是:一种以患者为中心的评估心血管疾病相关生活质量的工具。
Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):722-729. doi: 10.1093/ehjqcco/qcab079.
4
Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.射血分数保留的心力衰竭患者的生活质量:肥胖、功能能力和体力活动不足的重要性。
Eur J Heart Fail. 2020 Jun;22(6):1009-1018. doi: 10.1002/ejhf.1788. Epub 2020 Mar 9.
5
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.射血分数保留的心力衰竭患者的健康相关生活质量:PARAGON-HF 试验。
JACC Heart Fail. 2019 Oct;7(10):862-874. doi: 10.1016/j.jchf.2019.05.015. Epub 2019 Jul 10.
6
Using health-related quality of life to predict cardiovascular disease events.使用健康相关生活质量来预测心血管疾病事件。
Qual Life Res. 2019 Jun;28(6):1465-1475. doi: 10.1007/s11136-019-02103-1. Epub 2019 Jan 10.
7
Reduced levels of vasopressin, an independent mechanism in the obesity paradox in patients with chronic heart failure: Insights from the DAMOCLES study.精氨酸加压素水平降低是慢性心力衰竭患者肥胖悖论的独立机制:来自 DAMOCLES 研究的见解。
Int J Cardiol. 2019 Feb 1;276:171-176. doi: 10.1016/j.ijcard.2018.10.094. Epub 2018 Oct 29.
8
Obesity and the Obesity Paradox in Heart Failure.肥胖与心力衰竭中的肥胖悖论。
Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):151-156. doi: 10.1016/j.pcad.2018.05.005. Epub 2018 May 28.
9
Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.真实世界中心力衰竭的流行病学与转归:基于88195例患者的人群分析。
PLoS One. 2017 Feb 24;12(2):e0172745. doi: 10.1371/journal.pone.0172745. eCollection 2017.
10
Obesity and Heart Failure: Focus on the Obesity Paradox.肥胖与心力衰竭:聚焦肥胖悖论
Mayo Clin Proc. 2017 Feb;92(2):266-279. doi: 10.1016/j.mayocp.2016.11.001. Epub 2017 Jan 18.